YSCH-01

N/A

Report date: 2026/04/21 20:00:18

Base Information

Drug NameYSCH-01
Drug Alias Name重组L-IFN腺病毒Recombinant L-IFN Adenovirus InjectionRecombinant L-IFN adenovirusRecombinant oncolytic adenovirus L-IFNOncolytic adenovirus +[6] 
ClassificationBiologics > Oncolytic virus
Mechanisms of ActionInterferons stimulantsCell death stimulants
TargetsInterferons
Therapy Area/IndicationsSolid tumoursUrinary Bladder NeoplasmsUterine Cervical Neoplasms +[10] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesMainland China
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaPhase 1 Clinical
Originator CompaniesShanghai Yuansong Biotechnology Co Ltd
China Registration ClassClass 1 therapeutic biologic in China

Develop Information

Active CompaniesCancer Hospital Of Chinese Academy Of Medical SciencesShanghai Yuansong Biotechnology Co Ltd
Inactive CompaniesN/A
Active IndicationsSolid tumoursGlioblastomaNeoplasms
Inactive IndicationsUrinary Bladder NeoplasmsUterine Cervical NeoplasmsLung Neoplasms +[7] 

Other Information

ATC CodeN/A
Related LinksN/A